{
  "id": 322,
  "text": "Pooled SN detection rate in patients with a history of pre-operative treatments such as neoadjuvant chemotherapy or radiotherapy was low, however, pooled sensitivity remained high.Finally, larger tumour size $\\mathrm { ( > 2 ~ c m ) }$ ) and a more advanced stage ( $\\mathrm { \\hat { ~ } } >$ FIGO stage Ib2) were associated with low detection rate and sensitivity.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Pooled SN detection rate in patients with a history of pre-operative treatments such as neoadjuvant chemotherapy or radiotherapy was low, however, pooled sensitivity remained high.Finally, larger tumour size $\\mathrm { ( > 2 ~ c m ) }$ ) and a more advanced stage ( $\\mathrm { \\hat { ~ } } >$ FIGO stage Ib2) were associated with low detection rate and sensitivity.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在接受术前治疗（如新辅助化疗或放疗）的宫颈癌患者中，前哨淋巴结的检测率较低，这可能与治疗对淋巴结和淋巴管的影响有关，导致检测难度增加。另外，较大的肿瘤（大于2厘米）和更晚期的FIGO分期（超过Ib2期）也与较低的检测率和敏感性有关。这可能是因为较大的肿瘤和晚期肿瘤通常伴随着更复杂的病理和更广泛的淋巴结转移，使得前哨淋巴结难以被准确检测和识别。",
  "query": "哪些因素导致接受术前治疗的宫颈癌患者的前哨淋巴结检测率较低？另外，肿瘤大小和FIGO分期如何影响检测率和敏感性？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 哪些因素导致接受术前治疗的宫颈癌患者的前哨淋巴结检测率较低？另外，肿瘤大小和FIGO分期如何影响检测率和敏感性？\n\n<reference text>: Pooled SN detection rate in patients with a history of pre-operative treatments such as neoadjuvant chemotherapy or radiotherapy was low, however, pooled sensitivity remained high.Finally, larger tumour size $\\mathrm { ( > 2 ~ c m ) }$ ) and a more advanced stage ( $\\mathrm { \\hat { ~ } } >$ FIGO stage Ib2) were associated with low detection rate and sensitivity.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在接受术前治疗（如新辅助化疗或放疗）的宫颈癌患者中，前哨淋巴结的检测率较低，这可能与治疗对淋巴结和淋巴管的影响有关，导致检测难度增加。另外，较大的肿瘤（大于2厘米）和更晚期的FIGO分期（超过Ib2期）也与较低的检测率和敏感性有关。这可能是因为较大的肿瘤和晚期肿瘤通常伴随着更复杂的病理和更广泛的淋巴结转移，使得前哨淋巴结难以被准确检测和识别。"
}